Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| 17775 (NSD) | Other Identifier | Norwegian Social Science Data Services (registry for approval of data protection) | |
| 07/5829 (SHdir) | Other Identifier | The Norwegian Directorate of Health and Social Affairs (Approval of research biobank) | |
| 3.2007.2620 | Other Identifier | West Regional Committee of Research Ethics |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Addison's disease is a rare disease, wherein the adrenals can not produce sufficient steroid hormones (cortisol and aldosterone). Patients with Addison's disease report impaired subjective health status, and they have increased all-cause mortality. Conventional therapy is by oral replacement of glucocorticoid and mineralocorticoid hormones, but this strategy imperfectly mimic the diurnal cortisol variations, and render the patients both over- and under-treated. Anecdotally, some patients with adrenal insufficiency may benefit from the use of various nutritional compounds. We hypothesised that liquorice and grapefruit altered the metabolism and absorption of cortisone acetate.
In the present study, cortisone acetate absorption and metabolism are assessed in subjects with Addison's disease on three occasions. On the first occasion, the subjects are on their regular diet, but avoid ingestion of grapefruit and liquorice. At the end of the baseline assessment the order of the nutritional compounds (liquorice-grapefruit juice or grapefruit juice-liquorice) to be investigated in the next two assessments are randomised.
On the two next occasions, the absorption and metabolism of cortisone acetate is studied when study subjects consume liquorice and grapefruit juice. Between the use of grapefruit and liquorice there is a wash out period of at least 3 weeks.
For studies on liquorice effects, the subjects ingest 24-gram liquorice per day (equivalent of 150-mg glycyrrhizinic acid per day). For studies on grapefruit juice effects, subjects drink 200-ml grapefruit juice three times a day for three days. They maintain their regular medication and usual diet.
Time-series of cortisol and cortisone are obtained in serum and saliva samples on the third day of liquorice/grapefruit juice use. 24-hour urine is also collected.
Measurements of cortisol and metabolites in serum and saliva are used to calculate pharmacokinetical parameters. The measurements from samples obtained when using the investigated nutritional compounds are compared to the baseline assessment in each subject. Metabolites in 24-hour urine are compared similarly to investigate changes in urinary excretion, and to estimate the activity of enzymes involved in the metabolism of cortisol (5alfa-reductase, 5beta-reductase, cytochrome P450 3A4 system, 11-beta hydroxysteroid dehydrogenase).
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Liquorice | Active Comparator | Liquorice eq to 150 mg glycyrrhizinic acid. Results are compared to a baseline assessment without liquorice/grapefruit juice ingestion. |
|
| Grapefruit juice | Active Comparator | 200 ml pink grapefruit juice three times a day. Results are compared to a baseline assessment without liquorice/grapefruit juice ingestion. |
|
| Baseline | No Intervention | Baseline assessment without intake of liquorice or grapefruit juice |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Liquorice | Dietary Supplement | 24 gram liquorice eq. to 150 mg glycyrrhizinic acid, taken orally, for three days. |
|
| Measure | Description | Time Frame |
|---|---|---|
| AUC Serum Cortisol - Levels of cortisol in serum during the first 2.6 hours after oral administration of cortisone acetate. | The area under the curve (AUC) of cortisol is calculated based on serum time-series sampling (every 20 minutes for 2.6 h after oral administration of cortisone acetate). The AUCs obtained during liquorice and grapefruit juice intakes are compared to the baseline assessment (without these nutritional compounds). All other pharmacokinetic properties (primary and secondary outcome measures) are compared analogously. | Outcome measures are assessed when all subjects have completed the study, approximately 1.5-2.0 years after study start. |
| Measure | Description | Time Frame |
|---|---|---|
| Serum Cortisol levels at the end of time-series sampling (t=160min) | At the end of time series sampling (160 minutes after orally administered cortisone acetate) on all three assessments | Outcome measures are assessed when all subjects have completed the study, approximately 1.5-2.0 years after study start. |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Paal Methlie, MD | University of Bergen. Helse-Bergen HF | Principal Investigator |
| Kristian Løvås, MD, PhD | University of Bergen. Helse-Bergen HF. | Principal Investigator |
| Eystein S Husebye, Prof, MD | University of Bergen. Helse-Bergen HF. | Principal Investigator |
| Ernst A Lien, Prof. MD. | University of Bergen | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Haukeland University Hospital, Helse-Bergen HF | Bergen | 5020 | Norway |
Not provided
| ID | Term |
|---|---|
| D000224 | Addison Disease |
| ID | Term |
|---|---|
| D000309 | Adrenal Insufficiency |
| D000307 | Adrenal Gland Diseases |
| D004700 | Endocrine System Diseases |
| D001327 | Autoimmune Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| C000722286 | Glycyrrhiza glabra extract |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Grapefruit Juice | Dietary Supplement | 200 ml pink grapefruit juice three times a day, taken orally, for three days. |
|
| Serum Cortisone levels at the end of time-series sampling (t=160min) |
At the end of time series sampling (160 minutes after orally administered cortisone acetate) on all three assessments |
| Outcome measures are assessed when all subjects have completed the study, approximately 1.5-2.0 years after study start. |
| Saliva Cortisol levels at the end of time-series sampling (t=160min) | At the end of time series sampling (160 minutes after orally administered cortisone acetate) on all three assessments | Outcome measures are assessed when all subjects have completed the study, approximately 1.5-2.0 years after study start. |
| Saliva Cortisone levels at the end of time-series sampling (t=160min) | At the end of time series sampling (160 minutes after orally administered cortisone acetate) on all three assessments | Outcome measures are assessed when all subjects have completed the study, approximately 1.5-2.0 years after study start. |
| Time of maximum concentration of serum Cortisol | Based on time-series sampling at each of the three assessments | Outcome measures are assessed when all subjects have completed the study, approximately 1.5-2.0 years after study start. |
| Time of maximum concentration of serum Cortisone | Based on time-series sampling at each of the three assessments | Outcome measures are assessed when all subjects have completed the study, approximately 1.5-2.0 years after study start. |
| Time of maximum concentration of Saliva Cortisol | Based on time-series sampling at each of the three assessments | Outcome measures are assessed when all subjects have completed the study, approximately 1.5-2.0 years after study start. |
| Time of maximum concentration of Saliva Cortisone | Based on time-series sampling at each of the three assessments | Outcome measures are assessed when all subjects have completed the study, approximately 1.5-2.0 years after study start. |
| Half life of serum cortisol | Based on time-series sampling at each of the three assessments | Outcome measures are assessed when all subjects have completed the study, approximately 1.5-2.0 years after study start. |
| Half life of serum cortisone | Based on time-series sampling at each of the three assessments | Outcome measures are assessed when all subjects have completed the study, approximately 1.5-2.0 years after study start. |
| Urinary aTHF/THF-ratio | Measured in 24h urine obtained at the three assessments. aTHF = allo-tetrahydrocortisol, THF = tetrahydrocortisol | Outcome measures are assessed when all subjects have completed the study, approximately 1.5-2.0 years after study start. |
| AUC Serum Cortisone | Similar to primary outcome Serum AUC Cortisol | Outcome measures are assessed when all subjects have completed the study, approximately 1.5-2.0 years after study start. |
| Urine total metabolites (Urinary cortisol+cortisone+6OHF+aTHF+THF+THE) | 24-hour urine collected on each of the three assessments aTHF = allo-tetrahydrocortisol, THF = tetrahydrocortisol, THE = tetrahydrocortisone, 6OHF = 6beta-hydroxycortisol | Outcome measures are assessed when all subjects have completed the study, approximately 1.5-2.0 years after study start. |
| Urinary ratio (aTHF+THF)/THE | Assessed in 24h urine obtained at the three assessments (baseline, after liquorice and after grapefruit juice). It is an index of 5-reductase activity. 24-hour urine collected on each of the three assessments aTHF = allo-tetrahydrocortisol, THF = tetrahydrocortisol, THE = tetrahydrocortisone | Outcome measures are assessed when all subjects have completed the study, approximately 1.5-2.0 years after study start. |
| Urinary Ratio Cortisol/6beta-OH-Cortisol | Assess the enzymatic activity of CYP3A4 by the index urinary cortisol/6beta-oh cortisol ratio obtained at the three assessments (baseline, after liquorice and after grapefruit juice. 6OHF = 6beta-hydroxycortisol | Outcome measures are assessed when all subjects have completed the study, approximately 1.5-2.0 years after study start. |
| Urine total metabolites (Urinary cortisol+cortisone+6OHF+aTHF+THF+THE) | 24-hour urine collected on each of the three assessments 24-hour urine collected on each of the three assessments aTHF = allo-tetrahydrocortisol, THF = tetrahydrocortisol, THE = tetrahydrocortisone, 6OHF = 6beta-hydroxycortisol | Outcome measures are assessed when all subjects have completed the study, approximately 1.5-2.0 years after study start. |
| AUC Saliva cortisone | Similar to primary outcome Saliva AUC Cortisol, but for cortisone. | Outcome measures are assessed when all subjects have completed the study, approximately 1.5-2.0 years after study start. |
| AUC Serum Cortisone | Similar to primary outcome Serum AUC Cortisol, but for cortisone. | Outcome measures are assessed when all subjects have completed the study, approximately 1.5-2.0 years after study start. |
| AUC Saliva Cortisol | Similar to AUC Serum Cortisol, but measurements are on saliva. | Outcome measures are assessed when all subjects have completed the study, approximately 1.5-2.0 years after study start. |
| D007154 | Immune System Diseases |